{"schema_version":"1","generated_at":"2026-10-31T11:00:55.574Z","data_as_of":null,"url":"https://www.findmykol.com/kol/aaron-franke","json_url":"https://www.findmykol.com/kol/aaron-franke/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"aaron-franke","name":"Aaron Franke","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Sidney","state":"MT","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1730568403","orcid":"0000-0002-7882-9762","openalex":"A5059475534"},"summary":"Aaron Franke is an Oncology physician. OpenAlex indexes 38 publications with 695 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":38,"cited_by_count":695,"h_index":11,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"Tempus AI, Inc","program_year":2025,"amount_usd":124.65,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1730568403"},{"payer":"Adaptive Biotechnologies Corporation","program_year":2025,"amount_usd":75.15,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1730568403"},{"payer":"Novocure Inc.","program_year":2025,"amount_usd":25.49,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1730568403"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1730568403","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":30.4,"classes_total":4,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":15.2,"drugs":[{"name":"Letrozole","share_pct":100}],"max_beneficiaries":13},{"class":"Antimetabolite","setting":"prescribed","share_pct":5.8,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":26.5,"classes_total":2,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":14.8,"drugs":[{"name":"Ondansetron Hcl","share_pct":57.9},{"name":"Ondansetron Odt","share_pct":42.1}],"max_beneficiaries":null},{"class":"Corticosteroid","setting":"prescribed","share_pct":11.7,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":20.2,"classes_total":2,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":13.2,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":26},{"class":"Atypical Antipsychotic","setting":"prescribed","share_pct":7,"drugs":[{"name":"Olanzapine","share_pct":100}],"max_beneficiaries":15}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":43,"shown":5,"withheld":38,"matched_by":"OpenAlex author record","recent":[{"title":"Porphyria Cutanea Tarda in a Patient With Hereditary Hemochromatosis: A Complex Overlap Disorder","year":2024,"journal":"Cureus","source_url":"https://doi.org/10.7759/cureus.74091","status":"verified"},{"title":"Re-ORIENT-ing antitumor immunity in EGFR-mutant non-small cell lung cancer: are antiangiogenics the key?","year":2023,"journal":"Chinese Clinical Oncology","source_url":"https://doi.org/10.21037/cco-23-28","status":"verified"},{"title":"Results of a phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response pathway deficient neoplasms.","year":2022,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.3122","status":"verified"},{"title":"Impact of Institutional Universal Microsatellite-Instability (MSI) Reflex Testing on Molecular Profiling Differences Between Younger and Older Patients with Colorectal Cancer","year":2022,"journal":"Clinical Colorectal Cancer","source_url":"https://doi.org/10.1016/j.clcc.2022.09.004","status":"verified"},{"title":"Extremely delayed-onset post-transplant lymphoproliferative disorder in a renal transplant patient","year":2022,"journal":"BMJ Case Reports","source_url":"https://doi.org/10.1136/bcr-2022-250625","status":"verified"}],"source":"works"},"contact":{"address_1":"216 14TH AVE SW","city":"Sidney","state":"MT","zip":"592703519","phone":"406-488-2504","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1730568403","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":6,"publications":38}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-07-03","provider_certified":"2023-07-01","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}